Cargando…
Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands
There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne β-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriace...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527366/ https://www.ncbi.nlm.nih.gov/pubmed/23284886 http://dx.doi.org/10.1371/journal.pone.0052102 |
_version_ | 1782253707039080448 |
---|---|
author | Voets, Guido M. Platteel, Tamara N. Fluit, Ad C. Scharringa, Jelle Schapendonk, Claudia M. Stuart, James Cohen Bonten, Marc J. M. Hall, Maurine A. L. |
author_facet | Voets, Guido M. Platteel, Tamara N. Fluit, Ad C. Scharringa, Jelle Schapendonk, Claudia M. Stuart, James Cohen Bonten, Marc J. M. Hall, Maurine A. L. |
author_sort | Voets, Guido M. |
collection | PubMed |
description | There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne β-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriaceae with a minimal inhibitory concentration >1 mg/L for ceftazidime/ceftriaxone from a national survey (75% E. coli, 11% E. cloacae, 11% K. pneumoniae, 2% K. oxytoca, 2% P. mirabilis). Isolates were investigated for extended-spectrum β-lactamases (ESBLs) and ampC genes using microarray, PCR, gene sequencing and molecular straintyping (Diversilab and multi-locus sequence typing (MLST)). ESBL genes were demonstrated in 512 isolates (81%); of which 446 (87%) belonged to the CTX-M family. Among 314 randomly selected and sequenced isolates, bla (CTX-M-15) was most prevalent (n = 124, 39%), followed by bla (CTX-M-1) (n = 47, 15%), bla (CTX-M-14) (n = 15, 5%), bla (SHV-12) (n = 24, 8%) and bla (TEM-52) (n = 13, 4%). Among 181 isolates with MIC ≥16 mg/L for cefoxitin plasmid encoded AmpCs were detected in 32 and 27 were of the CMY-2 group. Among 102 E. coli isolates with MIC ≥16 mg/L for cefoxitin ampC promoter mutations were identified in 29 (28%). Based on Diversilab genotyping of 608 isolates (similarity cut-off >98%) discriminatory indices of bacteria with ESBL and/or ampC genes were 0.994, 0.985 and 0.994 for E. coli, K. pneumoniae and E. cloacae, respectively. Based on similarity cut-off >95% two large clusters of E. coli were apparent (of 43 and 30 isolates) and 21 of 21 that were typed by belonged to ST131 of which 13 contained bla (CTX-M-15). Our findings demonstrate that bla (CTX-M-15) is the most prevalent ESBL and we report a larger than previously reported prevalence of ampC genes among Enterobacteriaceae responsible for resistance to third-generation cephalosporins. |
format | Online Article Text |
id | pubmed-3527366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35273662013-01-02 Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands Voets, Guido M. Platteel, Tamara N. Fluit, Ad C. Scharringa, Jelle Schapendonk, Claudia M. Stuart, James Cohen Bonten, Marc J. M. Hall, Maurine A. L. PLoS One Research Article There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne β-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriaceae with a minimal inhibitory concentration >1 mg/L for ceftazidime/ceftriaxone from a national survey (75% E. coli, 11% E. cloacae, 11% K. pneumoniae, 2% K. oxytoca, 2% P. mirabilis). Isolates were investigated for extended-spectrum β-lactamases (ESBLs) and ampC genes using microarray, PCR, gene sequencing and molecular straintyping (Diversilab and multi-locus sequence typing (MLST)). ESBL genes were demonstrated in 512 isolates (81%); of which 446 (87%) belonged to the CTX-M family. Among 314 randomly selected and sequenced isolates, bla (CTX-M-15) was most prevalent (n = 124, 39%), followed by bla (CTX-M-1) (n = 47, 15%), bla (CTX-M-14) (n = 15, 5%), bla (SHV-12) (n = 24, 8%) and bla (TEM-52) (n = 13, 4%). Among 181 isolates with MIC ≥16 mg/L for cefoxitin plasmid encoded AmpCs were detected in 32 and 27 were of the CMY-2 group. Among 102 E. coli isolates with MIC ≥16 mg/L for cefoxitin ampC promoter mutations were identified in 29 (28%). Based on Diversilab genotyping of 608 isolates (similarity cut-off >98%) discriminatory indices of bacteria with ESBL and/or ampC genes were 0.994, 0.985 and 0.994 for E. coli, K. pneumoniae and E. cloacae, respectively. Based on similarity cut-off >95% two large clusters of E. coli were apparent (of 43 and 30 isolates) and 21 of 21 that were typed by belonged to ST131 of which 13 contained bla (CTX-M-15). Our findings demonstrate that bla (CTX-M-15) is the most prevalent ESBL and we report a larger than previously reported prevalence of ampC genes among Enterobacteriaceae responsible for resistance to third-generation cephalosporins. Public Library of Science 2012-12-20 /pmc/articles/PMC3527366/ /pubmed/23284886 http://dx.doi.org/10.1371/journal.pone.0052102 Text en © 2012 Voets et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Voets, Guido M. Platteel, Tamara N. Fluit, Ad C. Scharringa, Jelle Schapendonk, Claudia M. Stuart, James Cohen Bonten, Marc J. M. Hall, Maurine A. L. Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands |
title | Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands |
title_full | Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands |
title_fullStr | Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands |
title_full_unstemmed | Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands |
title_short | Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands |
title_sort | population distribution of beta-lactamase conferring resistance to third-generation cephalosporins in human clinical enterobacteriaceae in the netherlands |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527366/ https://www.ncbi.nlm.nih.gov/pubmed/23284886 http://dx.doi.org/10.1371/journal.pone.0052102 |
work_keys_str_mv | AT voetsguidom populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT platteeltamaran populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT fluitadc populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT scharringajelle populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT schapendonkclaudiam populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT stuartjamescohen populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT bontenmarcjm populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT hallmaurineal populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands AT populationdistributionofbetalactamaseconferringresistancetothirdgenerationcephalosporinsinhumanclinicalenterobacteriaceaeinthenetherlands |